Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186795 · ClinicalTrials.gov registry record
Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 117
- Enrollment target
NCT02186795: Completed study, sponsored by Medical University of South Carolina.
NCT02186795 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 117 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02186795 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
Study Summary
The goal of this retrospective chart review is to evaluate if the implementation of lumbar plexus block placement for postoperative pain and administration of multimodal oral analgesia have improved conditions in the postoperative period for patients undergoing total hip arthroplasty when compared to the placement of epidurals for postoperative pain management.
Primary Outcome
Cumulative 48 Hours Opiate Consumption in Intravenous (IV) Morphine mg Equivalents (MME)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-03 |
What the finished NCT02186795 record still lists
NCT02186795 is an observational study that tracks outcomes without assigning an intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02186795 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02186795 about?
NCT02186795 is a clinical study titled "Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia". The goal of this retrospective chart review is to evaluate if the implementation of lumbar plexus block placement for postoperative pain and administration of multimodal oral analgesia have improved conditions in the postoperative period for patients undergoing total hip arthroplasty when compared t...
What is the current status of trial NCT02186795?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2013-04. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT02186795?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia